Print page Resize text Change font-size Change font-size Change font-size High contrast


       


 

 

 

About ENCePP

Find out more about the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

 

Are you a company seeking to commission or collaborate in the conduct of a post-authorisation study (PAS)?

Find out more

Do you wish to register a study in the EU PAS Register?

Find out more

Are you considering applying for an ENCePP study seal?

Read a personal account of the ENCePP study approval process

Are you interested in the recommendations from the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) on safety signals?

Review the list of signals discussed

 

 

 

Latest News
1 August 2014
New PROTECT benefit-risk website

The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) contains a number of work programmes whose goal is to strengthen the benefit-risk monitoring of medicines in Europe. Work program 5 (Benefit-Risk group) of PROTECT has developed a new website on available methods for benefit-risk evaluation and representation. It includes supporting tools and recommendations for use of benefit-risk methodologies and intends to be a guide for readers who are new to the world of benefit-risk assessment.

Related information:

» PROTECT benefit-risk website

» PROTECT project

14 July 2014

Third revision of the ENCePP Guide on Methodological Standards in Pharmacoepidemiology

The Guide is updated annually and revision 3 is now available on the ENCePP website. In addition to the revision or update of most chapters, it includes a new chapter on   'Design and analysis of pharmacogenetic studies', written in collaboration with the Special Interest Group in Molecular Epidemiology, Biomarkers and Pharmacogenetics of the International Society of Pharmacoepidemiology (ISPE).

Related information:

» ENCePP Guide on Methodological Standards in Pharmacoepidemiology

 

More news ...